Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Biometrics|September 2, 2005
Quantitative risk assessment for multivariate continuous outcomes with application to neurotoxicology: the bivariate caseZi-Fan Yu, Paul J CatalanoRisk Analysis : an Official Publication of the Society for Risk Analysis|July 18, 2008
A simulation study of quantitative risk assessment for bivariate continuous outcomesZi-Fan Yu, Paul J Catalano, Paul J CatzlanoTransfusion|March 10, 2018
Frequent source plasma donors are not at risk of iron depletion: the Ferritin Levels in Plasma Donor (FLIPD) studyGeorge B Schreiber, Roger Brinser, Marilyn Rosa-Bray, et al.The Journal of Thoracic and Cardiovascular Surgery|January 30, 2007
Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: a multicenter comparative trialJoseph E Bavaria, Jehangir J Appoo, Michel S Makaroun, et al.Clinical & Experimental Ophthalmology|July 12, 2017
Novel mobility test to assess functional vision in patients with inherited retinal dystrophiesDaniel C Chung, Sarah McCague, Zi-Fan Yu, et al.Pediatrics|June 3, 2005
Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatasePaul Harmatz, David Ketteridge, Roberto Giugliani, et al.European Journal of Heart Failure|January 28, 2014
The impact of kidney function on outcomes following high risk myocardial infarction: findings from 27 610 patientsGeorge V Moukarbel, Zi-Fan Yu, Kenneth Dickstein, et al.Ophthalmology|April 2, 2021
Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease: Phase 3 Results at 3 and 4 YearsAlbert M Maguire, Stephen Russell, Daniel C Chung, et al.Muscle & Nerve|November 18, 2017
A multicenter, retrospective medical record review of X-linked myotubular myopathy: The recensus studyAlan H Beggs, Barry J Byrne, Sabine De Chastonay, et al.The Journal of Pediatrics|May 2, 2006
Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyPaul Harmatz, Roberto Giugliani, Ida Schwartz, et al.Pageof 2